---
figid: PMC2939266__nihms-218965-f0003
figtitle: Dopamine-sensitive signaling via adenylyl cyclase (AC), phospholipase C
  (PLC), and phosphatidylinositol-3-kinase (PI3K) systems
organisms:
- NA
pmcid: PMC2939266
filename: nihms-218965-f0003.jpg
figlink: /pmc/articles/PMC2939266/figure/F3/
number: F3
caption: 'Schematic of dopamine-sensitive signaling via adenylyl cyclase (AC), phospholipase
  C (PLC), and phosphatidylinositol-3-kinase (PI3K) systems. This simplified view
  of the signaling pathways shows key downstream mediators and the various opportunities
  for interaction or integration among the pathways. Note the inhibitory effect of
  cyclic AMP-dependent protein kinase (PKA) on the activity of PLC, an action that
  provides a mechanism for crosstalk between the AC system and the PI/PLC systems.
  Besides hampering inositol trisphosphate (IP3)- mediated intracellular calcium mobilization
  (which would inhibit DARPP32 Thr34 phosphorylation via calmodulin/protein phosphatase
  2B), it may also be possible that inhibition of PIP2 (phosphatidylinositol-4,5-bisphosphate)
  utilization via PLC could shunt the phospholipid to the PI3K pathway. Red arrows
  depict inhibition, while yellow arrows depict stimulation. Abbreviations: DA, dopamine;
  DRD1, Dopamine receptor D1 subtype; DRD2, Dopamine receptor D2 subtype; DRD5, Dopamine
  receptor D5 subtype; cAMP, cyclic AMP; PKA, protein kinase A; EPAC, Exchange protein
  activated by cyclic AMP; PPtase1, protein phosphatase 1, MEKs/ERKs, mitogen-activated
  kinases; ATF1/CREM/CREB/CDP, illustrative transcription-regulatory factors; CamK-II,
  calcium-calmodulin-dependent protein kinase type II; DG, diacylglycerol; IP3R, inositol
  trisphosphate receptor; Ca2+, calcium ions within and exiting the endoplasmic storage;
  PIP3, phosphatidylinositol-3,4,5-trisphosphate; PTEN, phosphatase and tensin homolog;
  PDK-1, phosphoinositide-dependent kinase-1; Akt, protein kinase B; GSK3, glycogen
  synthase kinase-3; CcnD, cyclin D; mTOR, mammalian target of rapamycin; 4EBP1/eIF4E/p70S6K,
  downstream mediators to protein synthesis.'
papertitle: Pharmacology of Signaling Induced by Dopamine D1-Like Receptor Activation.
reftext: Ashiwel S. Undieh. Pharmacol Ther. ;128(1):37-60.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9477434
figid_alias: PMC2939266__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC2939266__F3
ndex: 848a55fd-defa-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2939266__nihms-218965-f0003.html
  '@type': Dataset
  description: 'Schematic of dopamine-sensitive signaling via adenylyl cyclase (AC),
    phospholipase C (PLC), and phosphatidylinositol-3-kinase (PI3K) systems. This
    simplified view of the signaling pathways shows key downstream mediators and the
    various opportunities for interaction or integration among the pathways. Note
    the inhibitory effect of cyclic AMP-dependent protein kinase (PKA) on the activity
    of PLC, an action that provides a mechanism for crosstalk between the AC system
    and the PI/PLC systems. Besides hampering inositol trisphosphate (IP3)- mediated
    intracellular calcium mobilization (which would inhibit DARPP32 Thr34 phosphorylation
    via calmodulin/protein phosphatase 2B), it may also be possible that inhibition
    of PIP2 (phosphatidylinositol-4,5-bisphosphate) utilization via PLC could shunt
    the phospholipid to the PI3K pathway. Red arrows depict inhibition, while yellow
    arrows depict stimulation. Abbreviations: DA, dopamine; DRD1, Dopamine receptor
    D1 subtype; DRD2, Dopamine receptor D2 subtype; DRD5, Dopamine receptor D5 subtype;
    cAMP, cyclic AMP; PKA, protein kinase A; EPAC, Exchange protein activated by cyclic
    AMP; PPtase1, protein phosphatase 1, MEKs/ERKs, mitogen-activated kinases; ATF1/CREM/CREB/CDP,
    illustrative transcription-regulatory factors; CamK-II, calcium-calmodulin-dependent
    protein kinase type II; DG, diacylglycerol; IP3R, inositol trisphosphate receptor;
    Ca2+, calcium ions within and exiting the endoplasmic storage; PIP3, phosphatidylinositol-3,4,5-trisphosphate;
    PTEN, phosphatase and tensin homolog; PDK-1, phosphoinositide-dependent kinase-1;
    Akt, protein kinase B; GSK3, glycogen synthase kinase-3; CcnD, cyclin D; mTOR,
    mammalian target of rapamycin; 4EBP1/eIF4E/p70S6K, downstream mediators to protein
    synthesis.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - da
  - nAChRalpha2
  - ord
  - Galphao
  - gb
  - Gbeta5
  - Gbeta13F
  - Gbeta76C
  - Galphai
  - gy
  - gas
  - Galphas
  - gd
  - Pten
  - ATPsynbeta
  - Atpalpha
  - Pdk1
  - norpA
  - sl
  - Plc21C
  - S6k
  - Mtor
  - Tor
  - pk
  - Akt
  - Dg
  - AP-1gamma
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pka-R2
  - Thor
  - Pka-C1
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Rap1
  - sgg
  - CrebB
  - CrebA
  - gs
  - CycE
  - cyc
  - CBP
  - nej
  - babo
  - DRD2
  - GNAO1
  - SUCLG2
  - GNB1
  - GNB2
  - GNB3
  - GNB4
  - GNB5
  - GAST
  - GALNS
  - PAGR1
  - PTEN
  - ATP8A2
  - PDK1
  - PDPK1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - RPS6KB1
  - RPS6KB2
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - TIMP1
  - EIF4EBP1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PPM1E
  - EIF4E
  - EIF4E2
  - EIF4E3
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - GSK3A
  - GSK3B
  - PPP1R1B
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - GNAS
  - GNAL
  - CND
  - CREBBP
  - OPN1LW
  - PAG1
  - PCBP4
  - GDNF
  - Cancer
---
